MDR Clinical Evaluation Reports for Lower-Risk Class Devices
It is known that the main objective of the implementation of the MDR was to strengthen the regulatory framework…
Resources & News
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 352–360 of 396
Key Takeaways from RAPS Euro Convergence: Advancing Regulatory Practices
The RAPS Euro Convergence Conference proved to be an exceptional gathering of regulatory professionals, offering an unparalleled level of…
PMPF Under the IVDR: Methods, Justifications, and Triggers
As we have mentioned in…
What is the Difference Between PMS and PMPF Under the IVDR?
While post-market clinical follow-up (PMCF) studies were a concept…
Linking IVDR Performance Evaluations and Risk Management
Similar to…
MDD Declaration of Conformity After 26 May 2021
As a regulatory representative for foreign manufacturers in the EU, UK, US, and Switzerland, MedEnvoy participated in several audits with…
Performance Evaluation Reports Under the IVDR
The performance evaluation report (PER) is the culmination of the application of the performance evaluation process to a specific IVD…
Ensuring Compliance for Foreign Manufacturers of CE Marked ‘Legacy Devices’: Common Pitfalls and Solutions
As a regulatory representative for foreign manufacturers including those who are CE marked ‘legacy device’ in the EU, Switzerland and…
The Relevance of Device Stability Studies to IVDR Performance Evaluation
Under the IVDR, the performance evaluation report (PER) is supported by three “sub-reports” comprising the scientific validity report (SVR),…
Showing 352–360 of 396